A single nucleotide polymorphism at chromosome 2q21.3 (LCT -13910C>T) associates with clinical outcome after allogeneic hematopoietic stem cell transplantation

Blood. 2008 Sep 1;112(5):2156-9. doi: 10.1182/blood-2008-02-139766. Epub 2008 Jun 10.

Abstract

A single nucleotide polymorphism (SNP) responsible for lactase persistence (LCT -13910C>T) changes intestinal microflora. Considering the influence of bacterial microflora on various immune effects, we tested DNA from 111 recipients/donors and analyzed whether this SNP interferes with survival and the incidence of acute graft-versus-host disease (aGVHD) after allogeneic hematopoetic stem cell transplantations (HSCT). Median overall survival (OS) was significantly longer when donors had a CC genotype (not reached after 133 vs 11.1 months, P = .004). Multivariate analysis identified a donor T allele (hazard ratio 2.63, 95% confidence interval 1.29-5.33, P = .008) as independent risk factor for death. Surprisingly, recipient genotypes did not influence outcome and there were no differences regarding aGVHD. Transplantation-related mortality (TRM), relapse and pneumonia were significantly less frequent in patients with CC donors. These findings add to the growing list of non-HLA polymorphisms with impact on outcome after allogeneic HSCT.

MeSH terms

  • Acute Disease
  • Adult
  • Alleles
  • Chromosomes, Human, Pair 2 / genetics*
  • Female
  • Genotype
  • Graft vs Host Disease / enzymology
  • Graft vs Host Disease / genetics
  • Graft vs Host Disease / immunology
  • Graft vs Host Disease / microbiology
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Intestines / enzymology
  • Intestines / immunology
  • Intestines / microbiology
  • Lactase / genetics
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide*
  • Prognosis
  • Risk Factors
  • Tissue Donors
  • Transplantation, Homologous

Substances

  • Lactase